4.9 out of 5.0, Based on: 9,913 reviews
Benzodiazepines are used as anticonvulsants, anxiolytics, hypnotics, and muscle relaxers. Because these drugs are highly effective, they are widely prescribed and used. Benzodiazepine medication are considered a controlled substance with significant risk of developing a substance use and addiction disorder. Additionally, there are significant drug-drug interactions with the combined use of benzodiazepines and medications used to treat mental illness, such as antipsychotic drugs, that clinicians should be aware of during crisis interventions. The basic pharmacology of benzodiazepines, benzodiazepine use disorder, withdrawal, and overdose, as well as treatment are discussed.
This course contains downloadable online lessons (PDF) and a practice test. When you're ready, purchase the course by clicking the "Add To Cart" button. This will let you take the test, complete the course evaluation and receive your certificate for CE credits.
- Describe the basic pharmacology of Benzodiazepines
- Explain the DSM-5 criteria for Benzodiazepine Use And Addiction Disorder
- Discuss Benzodiazepine withdrawal
II. Basic Pharmacology Of Benzodiazepines
III. Benzodiazepine Use And Addiction Disorder
1. DSM-5 Criteria
4. Clinical Course
IV. Benzodiazepine Withdrawal
1. Signs and Symptoms
V. Benzodiazepine Overdose
1. Clinical Presentation
VI. Case Study: Benzodiazepine Drug-Drug Interaction
VII. Future Trends Of Benzodiazepine Use
This organization, CE4Less, provider #1115, is approved as a provider for social work continuing education by the Association Of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education ACE) program. Ce4Less maintains responsibility for the program. ASWB Approval Period: 8/8/2018-8/8/2021. Social workers should contact their regulatory board To determine course approval. Social workers participating In this course will receive continuing education clock hours.
We are committed to providing our learners with unbiased information. Ce4Less never accepts commercial support and our authors have no significant financial or other conflicts of interest pertaining to the material